Theralase Technologies (TLT) Trading 6.1% Higher

Theralase Technologies Inc. (CVE:TLT) traded up 6.1% during mid-day trading on Monday . The stock traded as high as C$0.52 and last traded at C$0.52. 160,400 shares traded hands during trading, a decline of 58% from the average session volume of 382,736 shares. The stock had previously closed at C$0.49.

The company has a market cap of $68.03 million and a price-to-earnings ratio of -16.33.

TRADEMARK VIOLATION NOTICE: “Theralase Technologies (TLT) Trading 6.1% Higher” was reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece on another publication, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The legal version of this piece can be read at

About Theralase Technologies (CVE:TLT)

Theralase Technologies Inc, a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds and their associated drug formulations to destroy various cancers in Canada, the United States, and internationally. It operates in two divisions, Photo Dynamic Therapy and Therapeutic Laser Technology.

Featured Story: How to interpret a stock’s beta number

Receive News & Ratings for Theralase Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theralase Technologies and related companies with's FREE daily email newsletter.


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit